Literature DB >> 8212574

Evidence that the epidermal growth factor receptor on host cells confers reovirus infection efficiency.

J E Strong1, D Tang, P W Lee.   

Abstract

Reovirus binds to multiple sialoglycoproteins on the host cell surface. In an attempt to probe additional specific determinants that dictate host cell susceptibility to reovirus infection, we found that two mouse cell lines (NR6 and B82) previously shown to express no endogenous epidermal growth factor (EGF) receptors were relatively resistant to reovirus infection, whereas the same cell lines transfected with the gene encoding the EGF receptor manifested significantly higher susceptibility as determined by induction of cytopathic effects, viral protein synthesis, and plaque titration. This enhancement of infection efficiency requires a functional EGF receptor since it was not observed in cells expressing a mutated (kinase-inactive) EGF receptor. The observed difference in infection efficiency is not due to differences in virus binding or internalization. These studies suggest that the reovirus infection process is closely coupled to the EGF receptor-mediated cell signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8212574     DOI: 10.1006/viro.1993.1602

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  33 in total

1.  Reovirus as a novel oncolytic agent.

Authors:  K L Norman; P W Lee
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction.

Authors:  Hailin Yang; Sung-Kwon Kim; Mikyung Kim; Pedro A Reche; Tiara J Morehead; Inger K Damon; Raymond M Welsh; Ellis L Reinherz
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

3.  The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.

Authors:  M Kim; C T Williamson; J Prudhomme; D G Bebb; K Riabowol; P W K Lee; S P Lees-Miller; Y Mori; M M Rahman; G McFadden; R N Johnston
Journal:  Oncogene       Date:  2010-05-17       Impact factor: 9.867

4.  Linkage between reovirus-induced apoptosis and inhibition of cellular DNA synthesis: role of the S1 and M2 genes.

Authors:  K L Tyler; M K Squier; A L Brown; B Pike; D Willis; S M Oberhaus; T S Dermody; J J Cohen
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein sigma 1.

Authors:  K L Tyler; M K Squier; S E Rodgers; B E Schneider; S M Oberhaus; T A Grdina; J J Cohen; T S Dermody
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 6.  Advances in oncolytic virus therapy for glioma.

Authors:  Amy Haseley; Christopher Alvarez-Breckenridge; Abhik Ray Chaudhury; Balveen Kaur
Journal:  Recent Pat CNS Drug Discov       Date:  2009-01

7.  The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus.

Authors:  J E Strong; M C Coffey; D Tang; P Sabinin; P W Lee
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

8.  Reovirus-induced apoptosis is preceded by increased cellular calpain activity and is blocked by calpain inhibitors.

Authors:  R L Debiasi; M K Squier; B Pike; M Wynes; T S Dermody; J J Cohen; K L Tyler
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection.

Authors:  Kara L Norman; Kensuke Hirasawa; An-Dao Yang; Michael A Shields; Patrick W K Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

Review 10.  Evolution of malignant glioma treatment: from chemotherapy to vaccines to viruses.

Authors:  Richard Lee Price; Ennio Antonio Chiocca
Journal:  Neurosurgery       Date:  2014-08       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.